Effects of sociodemographic status, HIV disclosure, and self-reported adherence on treatment outcome among HIV/AIDS patients in south-western Nigeria
Article Sidebar
Main Article Content
Abstract
Background. HIV/AIDS is still a leading cause of death and a health threat to millions worldwide.
Objectives. To assess the effects of sociodemographic status, HIV disclosure, and self-reported adherence on treatment outcome among patients living with HIV in south-western Nigeria.
Methods. Four hundred and forty participants were recruited from six secondary health facilities offering antiretroviral therapy (ART) services in Osun State. A multistage sampling technique was used to select eligible participants. The level of significance was set at p<0.05.
Results. Of the participants, less than half (42.0%) had good knowledge on HIV and ART services, while 73.0% had good treatment adherence, about one-quarter (20.7%) had been stigmatised or discriminated against, and 58.4% had disclosed their status to their sexual partner; 75.5% of the partners were supportive afterwards. Treatment outcome was favourable for 86.4% of the participants, and there was a significant relationship between marital status and viral load suppression (p=0.003) and between adherence and viral load suppression (p=0.001). Participants with good adherence were 2.6 times more likely to have a favourable treatment outcome than those with poor adherence.
Conclusion. Adherence and marital status were found to be significantly associated with suppressed viral loads among people living with HIV.
Article Details
Issue
Section
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The SAJPH is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
How to Cite
References
1. HIV.gov. The global HIV/AIDS epidemic 2022. https://www.hiv.gov/federal-response/ pepfar-global-aids/global-hiv-aids-overview (accessed June 2024).
2. World Health Organization. Global HIV Programme: HIV data and statistics. Geneva: WHO, 2024 https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/hiv/ strategic-information/hiv-data-and-statistics (accessed June 2024).
3. Statista. Main causes of death in Nigeria 2019. 2021. https://www.statista.com/ statistics/1122916/main-causes-of-death-and-disability-in-nigeria/ (accessed June 2024).
4. Statista. People living with HIV in Nigeria in 2021. 2022. https://www.statista.com/
statistics/1128675/people-living-with-hiv-receiving-treatment-in-nigeria/ (accessed
June 2024).
5. Yu Y, Luo D, Chen X, Huang Z, Wang M, Xiao S. Medication adherence to antiretroviral
therapy among newly treated people living with HIV. BMC Public Health 2018;18:825.
https://doi.org/10.1186/s12889-018-5731-z
6. Cohen MS, Mastro TD, Cates W. Universal voluntary HIV testing and immediate antiretroviral therapy. Lancet 2009;373(9669):1077. https://doi.org/10.1016/S0140-6736(09)60640-1
7. Ntshakala T, Mavundla T, Dolamo B. Quality of life of people living with HIV and AIDS who
are on antiretroviral therapy in Swaziland. Afr J Nurs Midwifery 2015;17(1):17-32. https://
doi.org/10.25159/2520-5293/106
8. Bezabhe WM, Chalmers L, Bereznicki LR, Peterson GM. Adherence to antiretroviral therapy and virologic failure: A meta-analysis. Medicine (Baltimore) 2016;95(15):e3361. https://doi. org/10.1097/MD.0000000000003361
9. Okoronkwo I, Okeke U, Chinweuba A, Iheanacho P. Nonadherence factors and sociodemographic characteristics of HIV-infected adults receiving antiretroviral therapy in Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria. ISRN AIDS 2013;2013:843794. https://doi.org/10.1155/2013/843794
10. Pichon LC, Rossi KR, Ogg SA, Krull LJ, Griffin DY. Social support, stigma and disclosure: Examining the relationship with HIV medication adherence among Ryan White Program clients in the mid-south USA. Int J Env Res Public Health 2015;12(6):7073-7084. https://doi. org/10.3390/ijerph120607073
11. Salako A, Sholeye OO, Amoran EA. Disclosure of HIV status among clients accessing care at a tertiary health facility in Sagamu, southwestern Nigeria. Curr Res J Biol Sci 2022;8(2):18- 23. https://doi.org/10.19026/crjbs.8.2691
12. World Health Organization. Key facts HIV. July 2022. https://cdn.who.int/media/docs/ default-source/hq-hiv-hepatitis-and-stis-library/key-facts-hiv-2021-26july2022.pdf (accessed 4 October 2025).
13. World Health Organization. Considerations for developing a monitoring and evaluation framework for viral load testing. Geneva: WHO, 2019. https://iris.who.int/bitstream/ handle/10665/324745/WHO-CDS-HIV-19.5-eng.pdf (accessed June 2024).
14. Kahema SE, Mgabo MR, Emidi B, Sigalla GN, Kajeguka DC. Factors influencing adherence to antiretroviral therapy among HIV infected patients in Nyamagana-Mwanza, northern Tanzania: A cross-sectional study. Int Arch Med Microbiol 2018;1:002. https://doi. org/10.23937/iamm-2017/1710002
15. Tuot S, Sim J, Nagashima-Hayashi M. What are the determinants of antiretroviral therapy adherence among stable people living with HIV? A cross-sectional study in Cambodia. AIDS Res Ther 2023;20(1):47. https://doi.org/10.1186/s12981-023-00544-w
16. Steel G, Nwokike JI, Joshi MP. Development of a multi-method tool to measure ART adherence in resource-constrained settings: The South Africa experience. Arlington, Va.: Management Sciences for Health, 2007. https://www.semanticscholar.org/paper/ Development-of-a-multi-method-tool-to-measure-ART-Steel-Nwokike/7d548ccab52965 efcd3f9e14d80aab7aa05d7bfd (accessed 16 October 2025).
17. Chesney MA. The elusive gold standard: Future perspectives for HIV adherence assessment and intervention. J Acquir Immune Defic Syndr 2006;43(Suppl 1):149-155. https://doi. org/10.1097/01.qai.0000243112.91293.26
18. Da W, Li X, Qiao S, Zhou Y, Shen Z. Evaluation of self-report adherence measures and their associations with detectable viral load among people living with HIV (PLHIV) in China. PLoS ONE 2018;13(8):e0203032. https://doi.org/10.1371/journal.pone.0203032
19. Lam WY, Fresco P. Medication adherence measures: An overview. Biomed Res Int 2015;2015:217047. https://doi.org/10.1155/2015/217047
20. Banagi Yathiraj A, Unnikrishnan B, Ramapuram JT, et al. HIV-related knowledge among PLWHA attending a tertiary care hospital at coastal South India – a facility-based study. J Int Assoc Provid AIDS Care 2017;16(6):615-619. https://doi.org/10.1177/2325957417742671
21. Terblanche LM, Stellenberg EL. Patient knowledge of HIV and its treatment in South Africa. Afr J Prim Health Care Fam Med 2014;6(1):518. https://doi.org/10.4102/phcfm.v6i1.518 22. Talam NC, Gatongi P, Rotich J, Kimaiyo S. Factors affecting antiretroviral drug adherence
among HIV/AIDS adult patients attending HIV/AIDS clinic at Moi Teaching and Referral
Hospital, Eldoret, Kenya. East Afr J Public Health 2008;5(2):74-78.
23. Gultie T, Genet M, Sebsibie G. Disclosure of HIV-positive status to sexual partner and
associated factors among ART users in Mekelle Hospital. HIV AIDS (Auckl) 2015;7:209-214.
https://doi.org/10.2147/HIV.S84341
24. Shushtari ZJ, Salimi Y, Sajjadi H, Paykani T. Effect of social support interventions on adherence to antiretroviral therapy among people living with HIV: A systematic review and meta-analysis. AIDS Behav 2023;27(5):1619-1635. https://doi.org/10.1007/s10461- 022-03894-0
25. Gutin SA, Ruark A, Darbes LA, Neilands TB, Mkandawire J, Conroy AA. Supportive couple relationships buffer against the harms of HIV stigma on HIV treatment adherence. BMC Public Health 2023;23(1):1878. https://doi.org/10.1186/s12889-023-16762-w
26. Deribe K, Woldemichael K, Njau BJ, Yakob B, Biadgilign S, Amberbir A. Gender differences regarding barriers and motivators of HIV status disclosure among HIV-positive service users. SAHARA-J 2010;7(1):30-39. https://doi.org/10.1080/17290376.2010.9724953
27. Deribe K, Ebrahim J, Bush L. Outcomes and factors affecting HIV status disclosure to regular sexual partner among women attending antiretroviral treatment clinic. J AIDS Clin Res 2018;9:760. https://doi.org/10.4172/2155-6113.1000760
28. Kyere GA, Vechey GA, Charles-Unadike VO, Tarkang EE. Trends in viral load suppression among HIV patients on antiretroviral therapy (ART) at Asante Mampong Municipal Hospital, Ghana: 2019-2023. BMC Infect Dis 2024;24(1):1170. https://doi.org/10.1186/
s12879-024-10072-1